ECYT Has VISION, LPCN Up 50% In 5 Days, MYO On Watch, FDA Nod Boosts SRNE

Sorrento Therapeutics Inc. gained 17.75% today, following FDA approval of ZTlido, a next-generation non-opioid, lidocaine patch proposed for the relief of pain associated with post-herpetic neuralgia.

from RTT - Biotech http://ift.tt/2Fc8cd1
via IFTTT